Sanderling Ventures

Sanderling Ventures is a venture capital firm established in 1979 and headquartered in San Mateo, California, with additional offices in San Diego and Montreal. It focuses on seed and early-stage investments in the biomedical and healthcare technology sectors, while also participating in later-stage financings. Its portfolio targets opportunities in biotechnology, life sciences, therapeutics and pharmaceuticals, drug delivery, medical devices and instrumentation, imaging and diagnostics, medical informatics, healthcare information technology, eHealth, and healthcare services. The firm seeks opportunities across the United States and Canada.

Michael Dixon

Principal

Fred Middleton

Managing Director

Timothy C. Mills

Managing Director

Timothy Wollaeger

Managing Director

Past deals in Quebec

PreciThera

Series A in 2017
PreciThera is a biotechnology company dedicated to developing targeted therapies for rare bone diseases. It focuses on heterogeneous genetic disorders that primarily affect bone function, utilizing computational technology and a deep understanding of disease pathology to address both skeletal symptoms and extraskeletal issues.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.